These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 27870681)
21. Thermal ablation: update and technique at a high-volume institution. Krehbiel K; Ahmad A; Leyendecker J; Zagoria R Abdom Imaging; 2008; 33(6):695-706. PubMed ID: 18379836 [TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation of synchronous bilateral renal cell carcinoma. Zhang S; Zhao X; Ji C; Liu G; Li X; Zhang G; Gan W; Guo H Int J Urol; 2012 Mar; 19(3):241-7. PubMed ID: 22129157 [TBL] [Abstract][Full Text] [Related]
23. Early experience with percutaneous radiofrequency ablation of small solid renal masses. Roy-Choudhury SH; Cast JE; Cooksey G; Puri S; Breen DJ AJR Am J Roentgenol; 2003 Apr; 180(4):1055-61. PubMed ID: 12646454 [TBL] [Abstract][Full Text] [Related]
24. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123 [TBL] [Abstract][Full Text] [Related]
26. Nephron-sparing surgery--strategies for partial nephrectomy in renal cell carcinoma. Ljungberg B Scand J Surg; 2004; 93(2):126-31. PubMed ID: 15285564 [TBL] [Abstract][Full Text] [Related]
27. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: long-term clinical and oncologic outcomes. Chang X; Zhang F; Liu T; Ji C; Zhao X; Yang R; Yan X; Wang W; Guo H J Urol; 2015 Feb; 193(2):430-5. PubMed ID: 25106899 [TBL] [Abstract][Full Text] [Related]
29. Thermal ablation in renal cell carcinoma management: a comprehensive review. Wagstaff P; Ingels A; Zondervan P; de la Rosette JJ; Laguna MP Curr Opin Urol; 2014 Sep; 24(5):474-82. PubMed ID: 25051022 [TBL] [Abstract][Full Text] [Related]
30. Small renal tumors: natural history, observation strategies and emerging modalities of energy based tumor ablation. Derweesh IH; Novick AC Can J Urol; 2003 Jun; 10(3):1871-9. PubMed ID: 12892573 [TBL] [Abstract][Full Text] [Related]
34. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy. Goeman L; Joniau S; Oyen R; Van Poppel H Urology; 2006 Jan; 67(1):199. PubMed ID: 16413367 [TBL] [Abstract][Full Text] [Related]
35. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease. Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786 [TBL] [Abstract][Full Text] [Related]
36. Image-guided ablation of renal cell carcinoma. Hinshaw JL; Lee FT Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):429-47, vi. PubMed ID: 15271364 [TBL] [Abstract][Full Text] [Related]
37. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989 [TBL] [Abstract][Full Text] [Related]
38. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas. McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202 [TBL] [Abstract][Full Text] [Related]